Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?

MeSH terms

• Animals
• Anti-Arrhythmia Agents / administration & dosage
• Anti-Arrhythmia Agents / therapeutic use
• Atrial Fibrillation* / drug therapy
• Atrial Fibrillation* / physiopathology
• Benzhydryl Compounds* / therapeutic use
• Glucosides* / administration & dosage
• Glucosides* / therapeutic use
• Humans
• Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use